Fig. 5From: Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemiaThe effect of Apatinib on intracellular signaling pathways was examined by CyTOF at the single-cell level in primary ALL. The primary ALL cells were exposed to 20 μM Apatinib for 48 h, and subjected to CyTOF analysis of intracellular signaling pathways downstream of VEGFR2Back to article page